TST试验中的颅内出血
TST试验将近期缺血性卒中或短暂性脑缺血发作且伴脑血管或冠状动脉粥样硬化的患者随机分配至LDL胆固醇目标<70 mg/dL组或100±10 mg/dL组。中位随访3年,2860例患者中发生31例颅内出血,低目标组18例、高目标组13例,两组风险无显著差异;未控制的高血压和抗凝治疗为颅内出血的显著预测因素。
要点
- LDL胆固醇目标<70 mg/dL与100±10 mg/dL相比,颅内出血风险无显著增加。
- 治疗期间低LDL胆固醇不是颅内出血的预测因素。
- 未控制的高血压(HR 2.51)和抗凝治疗(HR 2.36)为颅内出血的显著预测因素。
核心结论
- 与LDL胆固醇目标100±10 mg/dL相比,目标<70 mg/dL在动脉粥样硬化性缺血性卒中患者中非显著地增加颅内出血风险。
- 发生的颅内出血与低LDL胆固醇无关。
- 未控制的高血压和抗凝治疗与颅内出血相关,具有重要临床意义。
研究设计与样本
- TST试验为随机对照试验,将既往3个月内缺血性卒中或15天内短暂性脑缺血发作且伴脑血管或冠状动脉粥样硬化证据的患者按1:1随机分配至LDL胆固醇目标<70 mg/dL组或100±10 mg/dL组,使用他汀或依折麦布。
- 共纳入2860例患者,中位随访3年。
主要发现
- 2860例患者中共发生31例颅内出血,低目标组18例、高目标组13例。
- 低目标组颅内出血发生率为3.21/1000患者年(95% CI 2.38-4.04),高目标组为2.32/1000患者年(95% CI 1.61-3.03)。
- 基线因素无颅内出血预测因素。
- 试验期间未控制的高血压(HR 2.51,95% CI 1.01-6.31,P=0.041)和抗凝治疗(HR 2.36,95% CI 1.00-5.62,P=0.047)为显著预测因素。
- 治疗期间低LDL胆固醇不是颅内出血的预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Although statins are effective in secondary prevention of ischemic stroke, they are also associated with an increase risk of intracranial hemorrhage (ICH) in certain conditions. In the TST trial (Treat Stroke to Target), we prespecified an exploration of the predictors of incident ICH. METHODS: Patients with ischemic stroke in the previous 3 months or transient ischemic attack within the previous 15 days and evidence of cerebrovascular or coronary artery atherosclerosis were randomly assigned in a 1:1 ratio to a target LDL (low-density lipoprotein) cholesterol of <70 mg/dL or 100±10 mg/dL, using statin or ezetimibe. RESULTS: Among 2860 patients enrolled, 31 incident ICH occurred over a median follow-up of 3 years (18 and 13 in the lower and higher target group, 3.21/1000 patient-years [95% CI, 2.38-4.04] and 2.32/1000 patient-years [95% CI, 1.61-3.03], respectively). While there were no baseline predictors of ICH, uncontrolled hypertension (HR, 2.51 [95% CI, 1.01-6.31], P=0.041) and being on anticoagulant (HR, 2.36 [95% CI, 1.00-5.62], P=0.047)] during the trial were significant predictors. On-treatment low LDL cholesterol was not a predictor of ICH. CONCLUSIONS: Targeting an LDL cholesterol of <70 mg/dL compared with 100±10 mg/dL in patients with atherosclerotic ischemic stroke nonsignificantly increased the risk of ICH. Incident ICHs were not associated with low LDL cholesterol. Uncontrolled hypertension and anticoagulant therapy were associated with ICH which has important clinical implications. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01252875; EUDRACT identifier: 2009-A01280-57.
引用
- Amarenco P, Kim JS, Labreuche J, et al. Intracranial Hemorrhage in the TST Trial. Stroke. 2021. PMID: 34963300. doi:10.1161/STROKEAHA.121.035846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。